101 related articles for article (PubMed ID: 22126199)
1. Chromatin: a key player in complex gene regulation and future cancer therapeutics.
Roukos DH
Epigenomics; 2011 Aug; 3(4):395-9. PubMed ID: 22126199
[No Abstract] [Full Text] [Related]
2. Promises and challenges of anticancer drugs that target the epigenome.
Verbrugge I; Johnstone RW; Bots M
Epigenomics; 2011 Oct; 3(5):547-65. PubMed ID: 22126246
[TBL] [Abstract][Full Text] [Related]
3. Targeting epigenetic networks with polypharmacology: a new avenue to tackle cancer.
Franci G; Miceli M; Altucci L
Epigenomics; 2010 Dec; 2(6):731-42. PubMed ID: 22122079
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitor apicidin downregulates DNA methyltransferase 1 expression and induces repressive histone modifications via recruitment of corepressor complex to promoter region in human cervix cancer cells.
You JS; Kang JK; Lee EK; Lee JC; Lee SH; Jeon YJ; Koh DH; Ahn SH; Seo DW; Lee HY; Cho EJ; Han JW
Oncogene; 2008 Feb; 27(10):1376-86. PubMed ID: 17828306
[TBL] [Abstract][Full Text] [Related]
5. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
Zhang Y; Fatima N; Dufau ML
Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
[TBL] [Abstract][Full Text] [Related]
6. Histone-deacetylase inhibitors: novel drugs for the treatment of cancer.
Johnstone RW
Nat Rev Drug Discov; 2002 Apr; 1(4):287-99. PubMed ID: 12120280
[TBL] [Abstract][Full Text] [Related]
7. Global epigenetic profiling in bladder cancer.
Dudziec E; Goepel JR; Catto JW
Epigenomics; 2011 Feb; 3(1):35-45. PubMed ID: 22126151
[TBL] [Abstract][Full Text] [Related]
8. Small molecule modulators in epigenetics: implications in gene expression and therapeutics.
Swaminathan V; Reddy BA; Ruthrotha Selvi B; Sukanya MS; Kundu TK
Subcell Biochem; 2007; 41():397-428. PubMed ID: 17484138
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitors--a new tool to treat cancer.
Somech R; Izraeli S; J Simon A
Cancer Treat Rev; 2004 Aug; 30(5):461-72. PubMed ID: 15245778
[TBL] [Abstract][Full Text] [Related]
10. Epigenetics in prostate cancer: biologic and clinical relevance.
Jerónimo C; Bastian PJ; Bjartell A; Carbone GM; Catto JW; Clark SJ; Henrique R; Nelson WG; Shariat SF
Eur Urol; 2011 Oct; 60(4):753-66. PubMed ID: 21719191
[TBL] [Abstract][Full Text] [Related]
11. DNMT3B interacts with hSNF2H chromatin remodeling enzyme, HDACs 1 and 2, and components of the histone methylation system.
Geiman TM; Sankpal UT; Robertson AK; Zhao Y; Zhao Y; Robertson KD
Biochem Biophys Res Commun; 2004 May; 318(2):544-55. PubMed ID: 15120635
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic analysis in the search for tumor suppressor genes.
Han ZG
Epigenomics; 2010 Aug; 2(4):489-93. PubMed ID: 22121966
[No Abstract] [Full Text] [Related]
13. Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines.
Osada H; Tatematsu Y; Sugito N; Horio Y; Takahashi T
Mol Carcinog; 2005 Dec; 44(4):233-41. PubMed ID: 16163707
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylases: complex transducers of nuclear signals.
Johnson CA; Turner BM
Semin Cell Dev Biol; 1999 Apr; 10(2):179-88. PubMed ID: 10441071
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic tête-à-tête: the bilateral relationship between chromatin modifications and DNA methylation.
D'Alessio AC; Szyf M
Biochem Cell Biol; 2006 Aug; 84(4):463-76. PubMed ID: 16936820
[TBL] [Abstract][Full Text] [Related]
16. The PHD finger/bromodomain of NoRC interacts with acetylated histone H4K16 and is sufficient for rDNA silencing.
Zhou Y; Grummt I
Curr Biol; 2005 Aug; 15(15):1434-8. PubMed ID: 16085498
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.
Stirzaker C; Song JZ; Davidson B; Clark SJ
Cancer Res; 2004 Jun; 64(11):3871-7. PubMed ID: 15172996
[TBL] [Abstract][Full Text] [Related]
18. Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer.
Wang LG; Beklemisheva A; Liu XM; Ferrari AC; Feng J; Chiao JW
Mol Carcinog; 2007 Jan; 46(1):24-31. PubMed ID: 16921492
[TBL] [Abstract][Full Text] [Related]
19. Epigenetics and cancer treatment.
Kristensen LS; Nielsen HM; Hansen LL
Eur J Pharmacol; 2009 Dec; 625(1-3):131-42. PubMed ID: 19836388
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic therapy in cancer: molecular background and clinical development of histone deacetylase and DNA methyltransferase inhibitors.
Schneider-Stock R; Ocker M
IDrugs; 2007 Aug; 10(8):557-61. PubMed ID: 17665331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
